Latest Dako Stories

GRAND RAPIDS, Mich. and GLOSTRUP, Denmark, May 16, 2012 /PRNewswire/ -- Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody. The MET4 Antibody, developed by George F. Vande Woude, Ph.D. and Brian Cao, M.D. of VARI and Beatrice Knudsen, M.D., Ph.D., formerly of the Fred Hutchinson Cancer Research Center, has...

COPENHAGEN, Feb. 25 /PRNewswire-FirstCall/ -- SuccessFactors, Inc. (Nasdaq: SFSF) today announced that its Danish partner, Effective Learning A/S, has signed a four-year contract with Dako, a worldwide provider of cancer diagnostic solutions. Dako has deployed SuccessFactors' Business Execution (BizX) Suite to build a global, transparent high-performance culture and better execute against its global growth plans. Dako is a global leader in tissue-based cancer diagnostics and provides...

Dako enters into collaboration with Bristol-Myers Squibb to develop clinical diagnostics to identify cancer patients who may receive greater benefits from certain drugs being developed by Bristol-Myers Squibb. Dako, a world-leading provider of cancer diagnostic solutions such as pharmDx(TM), has entered into a collaboration with Bristol-Myers Squibb Company (NYSE: BMY) to develop pharmacodiagnostic tests intended to identify patients more likely to benefit from treatment with certain...